Detailed price information for Tactile Systems Technology Inc (TCMD-Q) from The Globe and Mail including charting and trades.

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and ...

(MENAFN- GlobeNewsWire - Nasdaq) Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc.

About Tactile Systems Technology, Inc. (DBA Tactile Medical) Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions ...

In just over a year, Elaine Birkemeyer has transformed the financial position of Tactile Medical, a company devoted to lymphedema, lipedema and chronic venous insufficiency via at-home treatments.

Tactile Systems Technology ( (TCMD) ) has released its Q3 earnings. Here is a breakdown of the information Tactile Systems Technology presented ...

Authorizes Share Repurchase ProgramMINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company ...

Q3 2024 Earnings Call Transcript November 4, 2024 Tactile Systems Technology, Inc. beats earnings expectations. Reported EPS ...

We view this as a win for lymphedema patients and a positive for our business. As a brief context, the NCD policy for PCDs was established in 2002, and tactile followed that policy until 2015 when ...

Reports Q3 revenue $73.09M, consensus $76.01M. “In the third quarter, we delivered solid gross margin expansion, drove continued ...